Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients.
Dekkers C, Smits H, Stölzl D, Spekhorst L, Knol E, van Wijk F, Harder I, Werfel T, Schmitt J, Kleinheinz A, Abraham S, Thijs J, Weidinger S, de Bruin-Weller M, Bakker D, Drylewicz J.
Dekkers C, et al. Among authors: drylewicz j.
Clin Exp Allergy. 2024 Oct 24. doi: 10.1111/cea.14585. Online ahead of print.
Clin Exp Allergy. 2024.
PMID: 39449187
No abstract available.